PIRS - Pieris Pharmaceuticals Inc. (PIRS) CEO Stephen Yoder on Q1 2019 Results - Earnings Call Transcript
Pieris Pharmaceuticals, Inc. (PIRS)
Q1 2019 Results Earnings Conference Call
May 10, 2019 08:00 AM ET
Company Participants
Allan Reine - Chief Financial Officer
Stephen Yoder - CEO, President
Louis Matis - Senior VP & Chief Development Officer
Conference Call Participants
Chris Shibutani - Cowen and Company
Biren Amin - Jefferies
Matt Phipps - William Blair
Joe Pantginis - H.C. Wainwright
Presentation
Operator
Greetings, and welcome to the Pieris Pharmaceuticals Inc First Quarter 2019 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator